Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Liver Disease Diagnostics Market Size to Grow at a CAGR of 6.9% During the Forecast Period 2021-2026

(PharmaNewsWire.Com, January 30, 2022 ) Liver Disease Diagnostics market size was estimated at $31.34 million in 2020, growing at a CAGR of 6.9% during the forecast period 2021-2026. Liver disease diagnostics include a variety of tests such as magnetic resonance imaging, ultrasound, ct scan, biopsy and others that can help determine the status of the liver. The liver aids in the distribution of blood and processes throughout the body. It also aids in the coagulation of proteins in the blood, the detoxification of harmful compounds, and the usage of supplements. The presence of special compound in liver cells allows liver cells to execute synthetic reactions. When cells die, these compounds are released into the blood vessels, making it easier to dissect the liver during examinations. Infectious, immunological, genetic, and metabolic factors can all contribute to liver disease. Different causes of diseases make diagnosis difficult. As a result, multiple tests are required for a precise diagnosis of the disease's cause. Increasing number of acute and chronic liver diseases across the globe is one of the major factor driving the growth of the market. Increasing healthcare infrastructure and rising disposable income of the people is set to further enhance the overall market development of the Liver Disease Diagnostics Market for the period 2021-2026.



Liver Disease Diagnostics Market Segment Analysis By Diagnosis Technique



On the basis of diagnosis technique market for Liver Disease Diagnostics is categorized in Endoscopy, Biopsy, Imaging, Laboratory tests and others. Imaging segment in Liver Disease Diagnostics market held the largest share and is estimated to register higher CAGR of 7.1% during the forecast period 2021-2026. Ultrasound, X-ray, Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, and other types of imaging are available also growing number of key players in the market for liver disease diagnostics are investing in the development of advance imaging techniques thereby increasing Liver Disease Diagnostics market.



Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=19507

Report Price: $4500 (Single User License)



Liver Disease Diagnostics Market Segment Analysis By End-User



On the basis of end user market for Liver Disease Diagnostics is categorized in Hospitals, Laboratories and Others. Hospitals segment in Liver Disease Diagnostics market held the largest share. Hospitals provide patients with the best care and allow for early identification as well as improvement in the healthcare infrastructure thereby increasing Liver Disease Diagnostics market. However, Laboratories is estimated to register higher CAGR of 7.0% during the forecast period 2021-2026 owing to, to diagnose hepatic disorders, several labs and institutes have launched awareness campaigns.



Liver Disease Diagnostics Market Segment Analysis By Geography



North America dominated the Liver Disease Diagnostics market with a major share of 43% in 2020. This is attributed to increasing incidence of liver diseases in this region. According to the Centers for Disease Control and Prevention, between 800,000 and 1.4 million persons in the United States suffering from chronic hepatitis B. Furthermore, growing research and development in diagnostic tools by key players in this region which are contributing to the growth of the market in this region.



However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to rising government investment and funding in healthcare sector in this region. Increasing disposable income of the people coupled with rising number of diagnostic laboratories in this region is also increasing the growth of the market in this region.



Liver Disease Diagnostics Market Drivers



Increasing Prevalence of Liver Diseases



Increasing incidence of liver diseases including chronic liver disease is increasing the growth of the Liver Disease Diagnostics Market. According to the World Health Organization (WHO), globally around 841,080 new instances of liver cancer were reported and 781, 631 people died as a result of the disease. Additionally, increase in consumption of alcohol which leads to rise in number of liver cancer is also practiced to increase the growth of the Liver Disease Diagnostics market during the forecast period 2021-2026.



Increasing Technological Advancement



Increasing technological advancement in Liver Disease Diagnostics is increasing the growth of the Liver Disease Diagnostics market. Rising research and development activities by key players that helps to provide very sensitive and test assays for detecting liver disease thereby increasing the growth of the Liver Disease Diagnostics Market during the forecast period 2021-2026.



Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=19507



Liver Disease Diagnostics Market Challenges



Lack of Professional



Major factor that is set to impede the growth of the Liver Disease Diagnostics market is lack of professional. Another factor which hamper the growth of market is high price of imaging tests.



Liver Disease Diagnostics Market Landscape



Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Liver Disease Diagnostics Market. In 2020, the Liver Disease Diagnostics Market share is consolidated by the top ten players present in the market. The Liver Disease Diagnostics Market, top 10 companies are, Abbott, Siemens Healthcare GmbH., Fujifilm Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Merck & Co., Inc., Novartis AG, Pfizer, Inc. and Sanofi S.A.



Development:



In February 2019, Abbott got CE approval for a quick diagnostic test, Determine HBsAg 2 which is used for detecting hepatitis B surface antigen.



Key Takeaways



North America dominated the Liver Disease Diagnostics Market in 2020 owing to the increasing prevalence of liver diseases in this region. The Liver Disease Diagnostics Market scope for different regions will be provided in the final report.



Growing technological advancement in liver disease imaging technique is set to aid the market growth of the Liver Disease Diagnostics Market report.



Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the Liver Disease Diagnostics market will be provided in the Liver Disease Diagnostics Market report.



Lack of skilled professionals is poised to create the hurdles for the Liver Disease Diagnostics Market.



Related Reports:



A. Liver Function Tests Market

https://www.industryarc.com/Report/16156/liver-function-tests-market.html



B. Liver Transplantation Market

https://www.industryarc.com/Report/16104/liver-transplantation-market.html



For more Lifesciences and Healthcare Market related reports, please click here



About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

IndustryARC

Venkat Reddy

(+1) 970-236-3677

venkat@industryarc.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC